Treatment duration as a function of clinician-level patient volume: mechlorethamine treatment for mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL)

被引:0
|
作者
Querfeld, Christiane [1 ]
Pacheco, Theresa [2 ]
Haverkos, Bradley [2 ]
Binder, Gary [3 ]
Angello, James [3 ]
Poligone, Brian [4 ]
机构
[1] City Hope Comprehens Canc Ctr, Duarte, CA USA
[2] Univ Colorado, Denver, CO 80202 USA
[3] Helsinn Therapeut US, Woodbridge, NJ USA
[4] Rochester Skin Lymphoma Med Grp, Fairport, NY USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P-010
引用
收藏
页码:S8 / S8
页数:1
相关论文
共 50 条
  • [31] Chlormethine Gel for the Treatment of Mycosis Fungoides Cutaneous T-Cell Lymphoma: In Vitro Release and Permeation Testing
    Giuliano, Claudio
    Frizzarin, Stefano
    Alonzi, Alessandro
    Stimamiglio, Virginia
    Ortiz-Romero, Pablo L.
    DERMATOLOGY AND THERAPY, 2022, 12 (11) : 2517 - 2529
  • [32] Choosing a systemic treatment for advanced stage cutaneous T-cell lymphoma: mycosis fungoides and Sezary syndrome
    Duvic, Madeleine
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2015, : 529 - 544
  • [33] Palliative Local Radiotherapy in the Treatment of Tumor-stage Cutaneous T-cell Lymphoma/ Mycosis Fungoides
    Chen-chen Xu
    Tao Zhang
    Tao Wang
    Jie Liu
    Yue-hua Liu
    ChineseMedicalSciencesJournal, 2014, 29 (01) : 33 - 37
  • [34] A review of histone deacetylase inhibitors in the mycosis fungoides and Sezary syndrome cohorts of primary cutaneous t-cell lymphoma (CTCL)
    Papps, T.
    Vander Weyden, C.
    McCormack, C.
    Prince, M.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2018, 59 : 90 - 90
  • [35] Introduction: Cutaneous T-Cell lymphoma (CTCL) classification, staging, and treatment options
    Bagot, Martine
    DERMATOLOGIC CLINICS, 2008, 26 (01) : 3 - 12
  • [36] EXTRACORPOREAL PHOTOPHERESIS FOR THE TREATMENT OF 34 PATIENTS WITH CUTANEOUS T-CELL LYMPHOMA (CTCL)
    KOH, HK
    DAVIS, BE
    MEOLA, T
    LIM, HW
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 102 (04) : 567 - 567
  • [37] CYTOGENIC EFFECTS OF THE TREATMENT OF CUTANEOUS T-CELL LYMPHOMA (CTCL) BY EXTRACORPOREAL PHOTOPHERESIS
    KUSTER, W
    PETERSEIM, UM
    GEBAUER, HJ
    MESCHIG, R
    PLEWIG, G
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1988, 91 (04) : 410 - 410
  • [38] Specific Nail Alterations in Cutaneous T-Cell Lymphoma Successful Treatment With Topical Mechlorethamine
    Parmentier, Laurent
    Duerr, Caroline
    Vassella, Erik
    Beltraminelli, Helmut
    Borradori, Luca
    Haneke, Eckart
    ARCHIVES OF DERMATOLOGY, 2010, 146 (11) : 1287 - 1291
  • [39] Romidepsin for the treatment of relapsed/refractory cutaneous T-cell lymphoma (mycosis fungoides/Sezary syndrome): Use in a community setting
    Reddy, Sunil A.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 106 : 99 - 107
  • [40] The efficacy and safety of extracorporeal photopheresis (ECP) for treatment of mycosis fungoides and/or se′zary syndrome in cutaneous T-cell lymphoma
    Stone, V.
    Mesa, O. A.
    Covassin, L.
    McCloskey, C.
    Chuang, L. H.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S81 - S81